{"id":"W3134446480","doi":"10.1038/s41586-021-03412-7","title":"Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies","year":2021,"lang":"en","type":"article","venue":"Nature","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":716,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"NIHR BioResource; Directorate for Biological Sciences; National Institutes of Health; University Hospitals Coventry and Warwickshire NHS Trust; Warwick Medical School; Quadram Institute Bioscience; Oxford University Hospitals NHS Foundation Trust; Cambridge University Hospitals; Public Health Agency; Swansea University; Public Health England; Queen's University Belfast; University of Birmingham; University of Warwick; University of Oxford; University of Southampton; Wellcome Trust; Cancer Research UK; University College London; Queen's University; University of East Anglia; National Institute for Health and Care Research; University of Cambridge; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences; Fast Grants; National Institute of Allergy and Infectious Diseases; University Hospital Southampton NHS Foundation Trust; King's College Hospital NHS Foundation Trust; University of Exeter; Northumbria University; National Institute of General Medical Sciences; Public Health Wales; Burroughs Wellcome Fund; Bill and Melinda Gates Foundation; Fordham University; Medical Research Council; Department of Health and Social Care; Vir Biotechnology; King's College London; University of Portsmouth","keywords":"Virology; Antibody; Monoclonal antibody; Neutralization; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Receptor; Biology; Neutralizing antibody; Spike Protein; Messenger RNA; Virus; Coronavirus disease 2019 (COVID-19); Medicine; Gene; Immunology; Genetics; Infectious disease (medical specialty)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}